Government to sign off on CF drug deal next month
Negotiations between HSE and manufacturer Vertex over the drug's price enter final phase
The government expects to sign off on the purchase of life-changing cystic fibrosis drug Orkambi next month.
Protracted negotiations between the HSE and manufacturer Vertex over the price of the drug have entered the final phase, with a ten-year deal that encompasses other cystic fibrosis treatments like Kalydeco envisaged.
The exact price the state will pay for Orkambi is unclear, but it will be lower than the €159,000 per patient, per year rejected ...
